ID: ALA1778055

Max Phase: Preclinical

Molecular Formula: C38H71NO14

Molecular Weight: 765.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)CCO)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O

Standard InChI:  InChI=1S/C38H71NO14/c1-13-26-38(10,47)31(43)21(4)28(41)19(2)17-36(8,46)33(53-35-29(42)25(16-20(3)49-35)39(11)14-15-40)22(5)30(23(6)34(45)51-26)52-27-18-37(9,48-12)32(44)24(7)50-27/h19-33,35,40-44,46-47H,13-18H2,1-12H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1

Standard InChI Key:  PXQXUQWYHUXXSF-SZZIPPHSSA-N

Associated Targets(non-human)

Motilin receptor 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 765.98Molecular Weight (Monoisotopic): 765.4875AlogP: 0.94#Rotatable Bonds: 9
Polar Surface Area: 217.30Molecular Species: BASEHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.46CX Basic pKa: 8.90CX LogP: 1.23CX LogD: -0.28
Aromatic Rings: 0Heavy Atoms: 53QED Weighted: 0.16Np Likeness Score: 1.64

References

1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ..  (2011)  The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.,  21  (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078]

Source